| Patents for C07D 519 - Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or (11,041) |
|---|
| 08/18/2009 | CA2585557C Pyrazolo[4,3-d] pyrimidine derivatives useful as pde-5 inhibitors |
| 08/18/2009 | CA2219675C Pentacyclic compound |
| 08/13/2009 | WO2009098369A1 Antimitotic compounds derived from vinca alkaloids, preparation thereof and therapeutic use thereof |
| 08/13/2009 | CA2714419A1 Dual pharmacophores - pde4-muscarinic antagonistics |
| 08/13/2009 | CA2714418A1 Dual pharmacophores - pde4 -muscarinic antagonistics |
| 08/12/2009 | EP2086999A1 Inhibitors for disrupting the interaction of ubiquitination related enzymes and uses thereof |
| 08/12/2009 | CN101506207A Compound having pyridoindole ring structure having substituted pyridyl group attached thereto, and organic electroluminescence element |
| 08/11/2009 | US7572784 Inhibit Aurora kinase; cancer; 4-[9-Chloro-7-(2-fluoro-phenyl)-5H-benzo[c]pyrimido[4,5-e]azepin-2-ylamino]-N-(2-methylamino-ethyl)-benzamide; 9-Chloro-N-(4-{[3-(dimethylamino)azetidin-1-yl]carbonyl}phenyl)-7-(2-fluoro-6-methoxyphenyl)-5H-pyrimido[5,4-d][2]benzazepin-2-amine |
| 08/11/2009 | CA2359772C Cyclic substituted fused pyrrolocarbazoles and isoindolones |
| 08/11/2009 | CA2222552C N-oxides as antibacterial agents |
| 08/06/2009 | WO2009097446A1 Pyrazolopyrimidine pi3k inhibitor compounds and methods of use |
| 08/06/2009 | WO2009096445A1 Nerve trunk cell propagation accelerator |
| 08/06/2009 | WO2009096435A1 Condensed heterocyclic derivatives and uses thereof |
| 08/06/2009 | WO2009095787A1 Substituted heteroarylamide oxazepinopyrimidone derivatives |
| 08/06/2009 | WO2009095254A1 Pyrazolopyrimidines, a process for their preparation and their use as medicine |
| 08/06/2009 | US20090198454 Standard sample for test and /or calibration of circular dichroism dispersion meter and uv-visible spectrophotometer |
| 08/06/2009 | CA2713289A1 Substituted heteroarylamide diazepinopyrimidone derivatives |
| 08/06/2009 | CA2713248A1 Substituted heteroarylamide oxazepinopyrimidone derivatives |
| 08/06/2009 | CA2711759A1 Pyrazolopyrimidine pi3k inhibitor compounds and methods of use |
| 08/06/2009 | CA2711575A1 Pyrazolopyrimidines, a process for their preparation and their use as medicine |
| 08/05/2009 | EP2085400A1 Substituted heteroarylamide oxazepinopyrimidone derivatives |
| 08/05/2009 | EP2085398A1 Pyrazolopyrimidines, a process for their preparation and their use as medicine |
| 08/05/2009 | EP2084162A2 Bicyclic triazoles as protein kinase modulators |
| 08/05/2009 | EP2083844A2 Hcv ns3 protease inhibitors |
| 08/05/2009 | CN101501042A Pyrazolopyrimidines, a process for their preparation and their use as medicine |
| 08/05/2009 | CN101501037A Organic electroluminescent device and material for organic electroluminescent device |
| 08/05/2009 | CN101501036A Substituted pyrazolopyrimidines, a process for their preparation and their use as medicine |
| 08/05/2009 | CN101500563A Cycloalkanopyrolocarbazole derivatives and the use thereof as PARP, VEGFR2 and MLK3 inhibitors |
| 08/05/2009 | CN101497623A Compound containing imidazopyridine |
| 08/05/2009 | CN101497622A Pyridine methyl sulfinyl imidazopyridine derivative |
| 08/04/2009 | US7569569 Pyrrolo[2,3-d]pyrimidine compounds |
| 07/30/2009 | WO2009093008A1 Thieno-pyridine derivatives as mek inhibitors |
| 07/30/2009 | WO2009050242A3 Heterocycle-substituted piperazino-dihydrothienopyrimidines |
| 07/30/2009 | US20090192177 2-ARYL pyrrologpyrimidines for A1 and A3 receptors |
| 07/30/2009 | CA2711487A1 Quinolizidinone m1 receptor positive allosteric modulators |
| 07/29/2009 | EP2083014A2 Inhibitors of interleukin-1ß converting enzyme |
| 07/29/2009 | EP2081937A2 Triazolopyridazine protein kinase modulators |
| 07/29/2009 | EP1713809B1 Dimeric azacyclic compounds and their use |
| 07/29/2009 | CN101492465A 7,7'-diaza indirubin compounds for antineoplastic medicament |
| 07/29/2009 | CN101492464A Sulfhydryl imidazopyridine derivative containing dioxepane-pyridine |
| 07/29/2009 | CN101492463A Imidazopyridine derivative containing dioxane-pyridine |
| 07/29/2009 | CN100519560C Porphyrin/phthalocyanine dimer and tetramer directly bonded at pi system and processes for producing the same |
| 07/28/2009 | US7566727 2-(1-aza-bicyclo[2.2.2]oct-3-yl)-2,3-dihydro-isoindole-1-one/5,6-dihydro-furo[2,3-c] pyrrol-4-one derivative ligands for alpha 7 nicotinic acetylcholine receptor |
| 07/28/2009 | US7566725 2-(4-methylphenyl),3-(thien-2-yl-carbonyl),6-(methyl)imidazo(1,2-a)pyridine; GABA receptor inhibitors; anxiiolytic agents; sleep disorders (insomnia); psychological disorders; anticonvulsants; aggressiveness; antispasmodic agents; antidepressants/ bipolar disorders;cognition activators; analgesics |
| 07/28/2009 | US7566707 For example, 2-[3-(Tert-butyloxycarbonylamino)-piperidin-1-yl]-3-(2-butyn-1-yl)-5-[(dibenzo[b,f][1,4]-oxazepin-11-yl)methyl]-3,5-dihydro-imidazo[4,5-d]pyridazin-4-one; inhibiting effect on activity of the enzyme dipeptidylpeptidase-IV; use in treatment of diabetes mellitus, arthritis, obesity |
| 07/28/2009 | CA2462453C Azabicyclic-substituted fused-heteroaryl compounds for the treatment of disease |
| 07/23/2009 | WO2008060597A8 Compounds useful as protein kinase inhibitors |
| 07/23/2009 | US20090186889 Spiro-substituted pyrrolopyrimidines |
| 07/23/2009 | CA2712783A1 Beta-lactamase inhibitors |
| 07/22/2009 | EP2080762A1 Compound for organic electroluminescent device and organic electroluminescent device |
| 07/22/2009 | EP2079750A1 Dna complexing agents |
| 07/22/2009 | CN100516069C Process for preparing 6-alkylidene penem derivatives |
| 07/21/2009 | US7563901 potent antimicrobial activity and a wide antimicrobial spectrum in a safe and cost effective reaction |
| 07/21/2009 | US7563791 6-(Methoxymethyl)-5-(4-nitrophenyl)pyrrolo[2,1-f][1,2,4]triazin-4-amine; antiproliferative agents; angiogenesis inhibition; anticarcinogenic agents; breast cancer; colon cancer; antitumor agents |
| 07/21/2009 | CA2478393C 1-allyl ergot alkaloid derivatives, methods for their production and their use for migraine prevention and treatment |
| 07/21/2009 | CA2367921C Bicyclic heterocycles, processes for their preparation and their use as herbicides and pharmaceutical agents |
| 07/16/2009 | WO2009087364A1 Electroluminescent materials |
| 07/16/2009 | US20090181982 Substituted pyrroline kinase inhibitors |
| 07/15/2009 | EP2078721A2 Thieno-pyrimidime compounds having fungicidal activity |
| 07/15/2009 | EP2078010A2 Polycyclic heteroaryl substituted triazoles useful as axl inhibitors |
| 07/15/2009 | EP2078009A1 New fluorene derivatives, compositions containing the same and use thereof as inhibitors of the protein chaperone hsp 90 |
| 07/15/2009 | EP1458726B1 Mitotic kinesin inhibitors |
| 07/14/2009 | US7560454 1-(4-(10,11-dihydro-5H-pyrrolo[2,1-c](1,4)benzodiazepine-10-ylcarbonyl)-2-methyl-benzylcarbamoyl)-4methoxy-L-proline-N,N-dimethylamide; vasopressin agonists particularly useful in the treatment of urogenital disorders central diabetes insipidus, nocturnal enuresis and nocturia; blood disorders |
| 07/10/2009 | WO2008083367A2 Polycyclic heteroaryl substituted triazoles useful as axl inhibitors |
| 07/10/2009 | CA2710234A1 Polycyclic heteroaryl substituted triazoles useful as axl inhibitors |
| 07/09/2009 | US20090176806 protein kinase C or glycogen synthase kinase-3-beta inhibitors such as 3-(2-chlorophenyl)-4-[1-(3-hydroxypropyl)-1H-pyrrolo[2,3-b]pyridin-3-yl]-1H-pyrrole-2,5-dione, used for treating cardiovascular, skin, nervous system disorders and immunological disorders, diabetes, inflammatory diseases and cancer |
| 07/09/2009 | US20090176763 Azaindoles useful as inhibitors of JAK and other protein kinases |
| 07/09/2009 | US20090173916 Fluorescent diketopyrrolopyrroles |
| 07/08/2009 | EP2077268A1 Process for preparing inhibitors of nucleoside metabolism |
| 07/08/2009 | EP1495022B1 Diazabicyclo alkane derivatives with nk1 antagonistic activity |
| 07/08/2009 | CN100509811C Azaindoles |
| 07/07/2009 | US7557099 Pyrrolobenzodiazepines as key intermediates in the synthesis of dimeric cytotoxic pyrrolobenzodiazepines |
| 07/02/2009 | WO2009081197A1 Bicyclic derivatives for use in the treatment of androgen receptor associated conditions |
| 07/02/2009 | WO2009080682A1 Pyrrolo[2,3-d]pyrimidine derivatives as cgrp receptor antagonists |
| 07/02/2009 | WO2009079765A1 Compounds with activity at the 5-ht2c receptor |
| 07/02/2009 | US20090169560 Disulfide, sulfide, sulfoxide, and sulfone derivatives of cyclic sugars and uses thereof |
| 07/02/2009 | US20090169508 Opioid and opioid-like compounds and uses thereof |
| 07/02/2009 | CA2709514A1 Bicyclic derivatives for use in the treatment of androgen receptor associated conditions |
| 07/01/2009 | EP2074115A1 N3-heteroaryl substituted triazoles and n5-heteroaryl substituted triazoles useful as axl inhibitors |
| 07/01/2009 | CN100506825C Heterotricyclyl 6-alkylidene-penems as beta epsilontaualpha-lactamase inhibitors |
| 07/01/2009 | CN100506824C Preparation of 2,2'-di(3,4-ethylenedioxy-thiophene) |
| 06/30/2009 | US7553975 2-(((2-amino-1-oxo-3-mercapto-propyl)-amino)-methyl)-5-phenyl-thiazole-4-carbonyl-methionine; useful for treating restenosis or tissue proliferative diseases |
| 06/25/2009 | WO2009077741A2 3-substituted-4-0x0-3, 4-dihydro-imidazo- [5, 1-d] [1,2,3,5] -tetrazine-8-carboxylic acid amides as anticancer agents |
| 06/25/2009 | CA2709749A1 3-substituted-4-oxo-3,4-dihydro-imidazo[5,1-d][1,2,3,5]-tetrazine-8-carboxylic acid amides and their use |
| 06/24/2009 | CN100503608C Deazapurines and uses thereof |
| 06/23/2009 | US7550494 Small molecules useful in the treatment of inflammatory disease |
| 06/23/2009 | US7550455 8-(piperazin-1yl)- and 8-([1,4]diazepan-1yl)-xanthines, the preparation thereof and their use as pharmaceutical composition |
| 06/18/2009 | WO2009075359A1 Method of separating isomers of chiral substances and apparatus therefor |
| 06/18/2009 | WO2009037394A3 6-cycloamino-s-(pyridazin-4-yl)imidazo[1,2-b]-pyridazine and derivatives thereof preparation and therapeutic application thereof |
| 06/18/2009 | US20090156821 Quinazoline compounds |
| 06/18/2009 | US20090156630 Anti-tumour polycyclic carboxamides |
| 06/18/2009 | CA2707857A1 Organic compounds |
| 06/17/2009 | EP2070930A1 Polycycloalkylpurines as adenosine receptor antagonists |
| 06/11/2009 | US20090149468 Substituted heterocyclic compounds and methods of use |
| 06/10/2009 | EP2066324A2 Cycloalkanopyrolocarbazole derivatives and the use thereof as parp, vegfr2 and mlk3 inhibitors |
| 06/10/2009 | CN100497349C Improved Biapenem preparation method |
| 06/09/2009 | US7544693 Spirofuropyridine aryl derivatives |
| 06/09/2009 | US7544677 Cancer; 2-(methylthio)-6-phenyl-7-(4-{[4-(5-pyridin-2-yl-4H-1,2,4-triazol-3-yl)piperidin-1-yl]methyl}phenyl)pyrido[2,3-d]pyrimidine;serine/threonine kinase (Akt) suppression; increased cellular potency or solubility, greater selectivity, enhanced pharmacokinetic properties, lack of off target activity |
| 06/09/2009 | US7544312 Charge transport compositions and electronic devices made with such compositions |
| 06/04/2009 | WO2009069589A1 Novel naphthyridine derivative monohydrate and method for producing the same |